Breadcrumb

MeDiC  |  Metabolic Disorders and Complications Program

MeDiC Program News

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

RI-MUHC team studies a novel, fully automated insulin delivery system

A new publication in Lancet Digital Health describes an important step that may improve glucose control and quality of life for people with type 1...

The 2021 RI-MUHC Annual Report is online!

An invitation from Dr. Rhian Touyz

Discovery of mechanics of drug targets for COVID-19

Scientists unravel inner workings of cell receptors involved in inflammatory diseases

RI-MUHC scientist part of McGill team delivering World Alzheimer Report 2021

Alzheimer’s Disease International webinar launches report on World Alzheimer Day, September 21

In Memoriam: Hugh Bennett, PhD

Remembering a superb peptide chemist, exceptional collaborator and defender of student welfare

New G protein inhibitor identified, with potential for cancer therapies

RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells

RI-MUHC success in grant competition for transplantation research

Researchers awarded funds from the Canadian Donation and Transplantation Research Program for...

RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer

Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...

How does the hunger-suppressing hormone leptin cross the blood-brain barrier?

Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC

Explore news and events at the RI-MUHC